SEC Form 4 · accession 0001209191-18-055882
Krystal Biotech, Inc. · KRYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suma Krishnan
Officer — Chief Operating Officer · Director · 10% Owner
Period of report
Oct 18, 2018
Accepted (ET)
Oct 22, 2018 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711279
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 18, 2018 | P | 25,000 | $20.00 | A | 2,001,462 | D | |
| Common StockF1 | holding | — | — | — | 112,162 | I | By trust | |
| Common StockF2 | holding | — | — | — | 2,036,462 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- F2Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.